AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

3i Group PLC

Remuneration Information May 31, 2024

4732_dirs_2024-05-31_591e5818-27fa-49a1-bcbc-6e3f4319a6e4.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7224Q

3i Group PLC

31 May 2024

Market Abuse Regulation

MAR Article 19

On 31 May 2024, 3i Group plc (the "Company") was notified of the following.  

On 28 May 2024 share awards under the 3i Group Deferred Bonus Plan (the "Plan") held by the persons discharging managerial responsibilities ("PDMRs") named in the table below vested.  On that date the Shares shown in the column headed "Shares acquired" ceased to be subject to restrictions under the Plan.  The Shares (if any) shown in the column headed "Shares sold" were sold on 30 May 2024 at a price of £29.03325 per share.

PDMR Shares acquired Shares sold
S A Borrows 95,540 0
K J Dunn 43,853 0
J H Halai 14,594 6,920
J Hatchley 48,584 23,027
J Marie 14,956 7,091
S Moseley 149,095 70,620
B Sottomayor 59,945 59,945
On 28 May 2024 cash settled awards vesting under the Plan (under which a bonus is paid by reference to a number of notional Shares) held by the PDMRs named in the table below became payable.  On that date a bonus became payable in respect of a number of notional Shares shown in the column headed "Notional Shares vesting" based on a value equivalent to the price per share shown in the column headed "Price per share"
PDMR Notional Shares vesting Price per share
R Collins 29,831

  4,885
£29.50000

£29.03000
P De Jong 30,555

  2,349
£29,50000

£29.03000
P Wirtz 26,509

  2,349
£29.50000

£29.03000

The place of these transactions was the London Stock Exchange.

Ends 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHWPUCAAUPCGAG

Talk to a Data Expert

Have a question? We'll get back to you promptly.